The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Sertraline versus other antidepressive agents for depression
Abstract
BACKGROUND: The National Institute for Health and Clinical Excellence clinical practice guideline on the treatment of depressive disorder recommended that selective serotonin reuptake inhibitors should be the first-line option when drug therapy is indicated for a depressive episode. Preliminary evidence suggested that sertraline might be slightly superior in terms of effectiveness. OBJECTIVES: To assess the evidence for the efficacy, acceptability and tolerability of escitalopram in comparison with tricyclics (TCAs), heterocyclics, other SSRIs and newer agents in the acute-phase treatment of major depression. SEARCH STRATEGY: MEDLINE (1966 to 2008), EMBASE (1974 to 2008), the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Register and the Cochrane Central Register of Controlled Trials up to July 2008. No language restriction was applied. Reference lists of relevant papers and previous systematic reviews were hand-searched. Pharmaceutical companies and experts in this field were contacted for supplemental data. SELECTION CRITERIA: Randomised controlled trials allocating patients with major depression to sertraline versus any other antidepressive agent. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data. Discrepancies were resolved with another member of the team. A double-entry procedure was employed by two reviewers. Information extracted included study characteristics, participant characteristics, intervention details and outcome measures in terms of efficacy (the number of patients who responded or remitted), acceptability (the number of patients who failed to complete the study) and tolerability (side-effects). MAIN RESULTS: A total of 59 studies, mostly of low quality, were included in the review, involving multiple treatment comparisons between sertraline and other antidepressant agents. Evidence favouring sertraline over some other antidepressants for the acute phase treatment of major depression was found, either in terms of efficacy (fluoxetine) or acceptability/tolerability (amitriptyline, imipramine, paroxetine and mirtazapine). However, some differences favouring newer antidepressants in terms of efficacy (mirtazapine) and acceptability (bupropion) were also found. In terms of individual side effects, sertraline was generally associated with a higher rate of participants experiencing diarrhoea. AUTHORS' CONCLUSIONS: This systematic review and meta-analysis highlighted a trend in favour of sertraline over other antidepressive agents both in terms of efficacy and acceptability, using 95% confidence intervals and a conservative approach, with a random effects analysis. However, the included studies did not report on all the outcomes that were pre-specified in the protocol of this review. Outcomes of clear relevance to patients and clinicians were not reported in any of the included studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M. H., Freemantle, N., Boynton, J. R., Churchill, R. C., Eccles, M., Geddes, J. R., Hardy, R., Lewis, G., & Mason, J. M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 87
Self-citationRetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
The Whoqol Group (1998) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00009-4 · Cited by 3,802
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Self-citationImputing missing standard deviations in meta-analyses can provide accurate results
Furukawa, T. A., Barbui, C., Cipriani, A., Brambilla, P., & Watanabe, N. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.06.006 · Cited by 1,568
Self-citationSertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Statistics Notes: Detecting skewness from summary information: Table 1
Altman, D. G., & Bland, J. M. (1996) · BMJ · doi:10.1136/bmj.313.7066.1200 · Cited by 1,278
Network meta‐analysis for indirect treatment comparisons
Lumley, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1201 · Cited by 1,206
Evaluation of networks of randomized trials
Salanti, G., Higgins, J. P., Ades, A., & Ioannidis, J. P. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280207080643 · Cited by 1,078
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914
Assessing Evidence Inconsistency in Mixed Treatment Comparisons
Lu, G., & Ades, A. E. (2006) · Journal of the American Statistical Association · doi:10.1198/016214505000001302 · Cited by 756
Als-Nielsen, B., Chen, W., Gluud, C., & Kjaergard, L. L. (2003) · JAMA · doi:10.1001/jama.290.7.921 · Cited by 746
Lespérance, F., Frasure-Smith, N., Koszycki, D., Laliberté, M.-A., van Zyl, L. T., Baker, B., Swenson, J. R., Ghatavi, K., Abramson, B. L., Dorian, P., et al. (2007) · JAMA · doi:10.1001/jama.297.4.367 · Cited by 658
Bhandari, M., Busse, J. W., Jackowski, D., Montori, V. M., Schünemann, H. J., Sprague, S., Mears, D., Schemitsch, E. H., Heels-Ansdell, D., & Devereaux, P. J. (2004) · Europe PMC (PubMed Central) · Cited by 551
Smith, D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.396 · Cited by 538
Hypericum Depression Trial Study Group (2002) · JAMA · doi:10.1001/jama.287.14.1807 · Cited by 480
St John's wort for major depression
Linde, K., Berner, M. M., & Kriston, L. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000448.pub3 · Cited by 477
Awareness, diagnosis, and treatment of depression
the Council on Scientific Affairs, A. M. A., Goldman, L. S., Nielsen, N. H., & Champion, H. C. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.03478.x · Cited by 466
Clinicians' Judgments of Mental Health: A Proposed Scale
LUBORSKY, L. (1962) · Archives of General Psychiatry · doi:10.1001/archpsyc.1962.01720060019002 · Cited by 459
Williams, J. W., Mulrow, C. D., Chiquette, E., Noël, P. H., Aguilar, C., & Cornell, J. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00011 · Cited by 423
Bauer, M., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150599 · Cited by 346
Imputing response rates from means and standard deviations in meta-analyses
Furukawa, T. A., Cipriani, A., Barbui, C., Brambilla, P., & Watanabe, N. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200501000-00010 · Cited by 337
Self-citationPerlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318
Furukawa, T. A., Guyatt, G. H., & Griffith, L. E. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.72 · Cited by 318
Self-citationBollini, P., Pampaliona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.297 · Cited by 274
Reimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression
Royal Australian And New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For Depression (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01377.x · Cited by 257
Koe, B. K., Weissman, A., Welch, W. M., & Browne, R. G. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21773-6 · Cited by 257
Croft, H., Settle, E., Houser, T., Batey, S. R., Donahue, R. M. J., & Ascher, J. A. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88317-4 · Cited by 242
Bondareff, W., Alpert, M., Friedhoff, A. J., Richter, E. M., Clary, C. M., & Batzar, E. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.729 · Cited by 202
Feiger, A. D., Kiev, A., Shrivastava, R. K., Wisselink, P., & Wilcox, C. S. (1996) · PubMed · Cited by 185
Brenner, R., Azbel, V., Madhusoodanan, S., & Pawlowska, M. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)89010-4 · Cited by 176
Expanding the Black Box — Depression, Antidepressants, and the Risk of Suicide
Friedman, R. A., & Leon, A. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmp078015 · Cited by 174
Lawrenson, R., Tyrer, F., Newson, R. B., & Farmer, R. D. T. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00147-0 · Cited by 165
A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163
Khan, A., Khan, S. R., Walens, G., Kolts, R., & Giller, E. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300059 · Cited by 158
Furukawa, T. A., McGuire, H., & Barbui, C. (2002) · BMJ · doi:10.1136/bmj.325.7371.991 · Cited by 157
Self-citationFluoxetine versus other types of pharmacotherapy for depression
Cipriani, A., Brambilla, P., Furukawa, T. A., Geddes, J. R., Gregis, M., Hotopf, M. H., Malvini, L., & Barbui, C. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub2 · Cited by 156
Self-citationDouble-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients
Kavoussi, R. J., Segraves, R. T., Hughes, A. R., Ascher, J. A., & Johnston, J. A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1204 · Cited by 149
The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders
MacQUEEN, G. M., Born, L., & Steiner, M. S. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00188.x · Cited by 145
Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action Study
Behnke, K., Søgaard, J., Martin, S. D., Bäuml, J., Ravindran, A. V., Ågren, H., & Vester-Blokland, E. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000085408.08426.05 · Cited by 145
D, M. F. M., Rosenbaum, J. F., HOOG, S. L., Tepner, R. G., Kopp, J. B., & Nilsson, M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00131-7 · Cited by 140
Stahl, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00957-4 · Cited by 134
Coleman, C. C., Cunningham, L. A., Foster, V. J., Batey, S. R., Donahue, R. M. J., Houser, T. L., & Ascher, J. A. (1999) · Annals of Clinical Psychiatry · doi:10.1023/a:1022309428886 · Cited by 133
Industry Sponsorship and Authorship of Clinical Trials Over 20 Years
Buchkowsky, S. S., & Jewesson, P. J. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d267 · Cited by 132
Sir, A., D'Souza, R. F., Uguz, S., George, T., Vahip, S., Hopwood, M., Martin, A. J., Lam, W., & Burt, T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1015 · Cited by 129
Lydiard, R. B., Stahl, S. M., Hertzman, M., & Harrison, W. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1104 · Cited by 126
Søgaard, J., Lane, R. M., Latimer, P. R., Behnke, K., Christiansen, P. E., Nielsen, B. M., Ravindran, A. V., Reesal, R. T., & Goodwin, D. P. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300412 · Cited by 120
Montgomery, J. H., Byerly, M., Carmody, T. J., Li, B., Miller, D. R., Varghese, F. P., & Holland, R. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.09.002 · Cited by 117
Zanardi, R., Franchini, L., Gasperini, M., Perez, J., & Smeraldi, E. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1631 · Cited by 117
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression
Aguglia, E., Casacchia, M., Cassano, G. B., Faravelli, C., Ferrari, G., Giordano, P., Pancheri, P., Ravizza, L., Trabucchi, M., Bolino, F., et al. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00010 · Cited by 115
Probing the Safety of Medications in the Frail Elderly
Oslin, D. W., Have, T. R. T., Streim, J. E., Datto, C. J., Weintraub, D. A., DiFilippo, S. D., & Katz, I. R. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0804 · Cited by 115
Response to Phenelzine and Imipramine in Placebo Nonresponders With Atypical Depression
Quitkin, F. M. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280035005 · Cited by 113
(1995) · PubMed · Cited by 105
Malt, U. F., Robak, O. H., Madsbu, H.-P., Bakke, O., & Loeb, M. E. (1999) · BMJ · doi:10.1136/bmj.318.7192.1180 · Cited by 104
Relapse and recurrence in unipolar major depression: short-term and long-term approaches.
Thase, M. E. (1990) · PubMed · Cited by 103
Mehtonen, O. ‐., Søgaard, J., Roponen, P., Behnke, K., & Venlafaxine 631 Study Group (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0204 · Cited by 97
Åberg‐Wistedt, A., Ågren, H., Ekselius, L., Bengtson, F., & Åkerblad, A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00010 · Cited by 95
Ekselius, L., von Knorring, L., & Eberhard, G. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199711000-00005 · Cited by 92
D, M. F. M., HOOG, S. L., Judge, R., Kopp, J. B., Nilsson, M., & Gonzales, J. S. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00006 · Cited by 91
Are we going to increase the use of antidepressants up to that of benzodiazepines?
Ciuna, A., Andretta, M., Corbari, L., Levi, D., Mirandola, M., Sorio, A., & Barbui, C. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0810-8 · Cited by 87
Self-citationTreatment of anxiety and depressive disorders in patients with cardiovascular disease
Davies, S., Jackson, P., Potokar, J. P., & Nutt, D. (2004) · BMJ · doi:10.1136/bmj.328.7445.939 · Cited by 79
D, M. F. M., Nierenberg, A. A., Quitkin, F. M., Zisook, S., Pearlstein, T. B., Stone, A. B., & Rosenbaum, J. F. (1997) · PubMed · Cited by 77
Gastpar, M., Singer, A., & Zeller, K. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-837807 · Cited by 73
Feinstein, R. E., Blumenfield, M., Orlowski, B., Frishman, W. H., & Ovanessian, S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000200977.41695.43 · Cited by 66
Pharmacology of sertraline: a review.
Heym, J. H., & Koe, B. K. (1988) · PubMed · Cited by 65
Ventura, D., Armstrong, E. P., Skrepnek, G. H., & Erder, M. H. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x167273 · Cited by 62
Doogan, D. P., & Langdon, C. J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400920-00005 · Cited by 61
Why are so few randomized trials useful, and what can we do about it?
Zwarenstein, M., & Oxman, A. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.05.010 · Cited by 60
Sechter, D., Troy, S., Paternetti, S., & Boyer, P. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)80714-7 · Cited by 59
Procyshyn, R. M., Chau, A. M. T., Fortin, P. M., & Jenkins, W. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900905 · Cited by 57
Placebo in Clinical Trials for Depression: Complexity and Necessity
Kupfer, D. J., & Frank, E. (2002) · JAMA · doi:10.1001/jama.287.14.1853 · Cited by 55
Quednow, B. B., K�hn, K.-U., Stelzenmueller, R., Hoenig, K., Maier, W., & Wagner, M. (2003) · Psychopharmacology · doi:10.1007/s00213-004-1842-6 · Cited by 54
Nemeroff, C. B., Ninan, P. T., Ballenger, J., Lydiard, R. B., Feighner, J. P., Patterson, W. M., & Greist, J. H. (1995) · Depression · doi:10.1002/depr.3050030402 · Cited by 52
Moffaert, M. V., Bartholomé, F., Cosyns, P. R., Nayer, A. R. D., & Mertens, C. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100505 · Cited by 51
Shelton, R. C., Haman, K., Rapaport, M. H., Kiev, A., Smith, W. T., Hirschfeld, R. M. A., Lydiard, R. B., Zajecka, J., & Dünner, D. L. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1102 · Cited by 51
Munizza, C., Olivieri, L., Loreto, G. D., & Dionisio, P. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x121039 · Cited by 51
St John's wort or sertraline? Randomized controlled trial in primary care.
van Gurp, G., Meterissian, G. B., Haiek, L. N., McCusker, J., & Bellavance, F. (2002) · PubMed Central · Cited by 50
Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression
Boyer, P., Danion, J., Bisserbe, J. C., Hotton, J., & Troy, S. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813010-00015 · Cited by 49
Clinical trials of antidepressant medications are producing meaningless results
Parker, G. B., Anderson, I. M., & Haddad, P. M. (2003) · The British Journal of Psychiatry · doi:10.1192/bjp.183.2.102 · Cited by 49
Barbui, C., Guaiana, G., & Hotopf, M. H. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-818985 · Cited by 49
Self-citationSertraline Versus Fluvoxamine in the Treatment of Elderly Patients With Major Depression
Rossini, D., Serretti, A., Franchini, L., Mandelli, L., Smeraldi, E., Ronchi, D. D., & Zanardi, R. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000177548.28961.e7 · Cited by 44
Forlenza, O. V., Almeida, O. P., Stoppe, A., Hirata, E. S., & Ferreira, R. C. (2001) · International Psychogeriatrics · doi:10.1017/s1041610201007475 · Cited by 42
Moon, C. A. L., Jago, W., Wood, K., & Doogan, D. P. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800306 · Cited by 38
Möller, H.-J., Glaser, K., Leverkus, F., & Göbel, C. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-8357 · Cited by 37
Duloxetine versus other anti-depressive agents for depression
Nosè, M., Cipriani, A., Furukawa, T. A., Omori, I. M., Churchill, R. C., McGuire, H., & Barbui, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533 · Cited by 32
Self-citationThe impact of sertraline, desipramine, and placebo on psychomotor functioning in depression
Ravindran, A. V., Teehan, M. D., Bakish, D., Yatham, L. N., O’Reilly, R., Fernando, M. L. D., Manchanda, R., Charbonneau, Y., & Buttars, J. A. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100404 · Cited by 31
Suri, R., Altshuler, L. L., Rasgon, N. L., Calcagno, J. L., Frye, M. A., Gitlin, M. J., Hwang, S., & Zuckerbrow-Miller, J. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1209 · Cited by 31
O’Connor, C. M., Glassman, A. H., & Harrison, D. J. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0311 · Cited by 25
Venlafaxine for major depression
Cipriani, A., Geddes, J. R., & Barbui, C. (2007) · BMJ · doi:10.1136/bmj.39098.457720.be · Cited by 24
Self-citationFeiger, A. D., Flament, M. F., Boyer, P., & Gillespie, J. A. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200307000-00002 · Cited by 21
Bersani, G., Rapisarda, V., Ciani, N., Bertolino, A., & Sorge, G. (1994) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470090108 · Cited by 21
Szádóczky, E., & Füredi, J. (2002) · PubMed · Cited by 20
Lépine, J. P., Goger, J., Blashko, C., Probst, C., Moles, M.-F., Kosolowski, J., Scharfetter, B., & Lane, R. M. (2000) · International Clinical Psychopharmacology · doi:10.1097/00004850-200015050-00003 · Cited by 19
Eker, S. S., Akkaya, C., Akgöz, S., Sarandöl, A., & Kırlı, S. (2005) · PubMed · Cited by 17
Milnacipran versus other anti-depressive agents for depression
Nakagawa, A., Watanabe, N., Omori, I. M., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., Furukawa, T. A., & Ant, M.-A. O. N. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006529 · Cited by 16
Self-citationMirtazapine versus other anti-depressive agents for depression
Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., Furukawa, T. A., & Ant, M.-A. O. N. G. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006528 · Cited by 15
Self-citationParoxetine versus other anti-depressive agents for depression
Cipriani, A., Furukawa, T. A., Veronese, A., Watanabe, N., Churchill, R. C., McGuire, H., & Barbui, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006531 · Cited by 15
Self-citationBaca, E., GonzálezdeChávez, M., García-Toro, M., Perez-Arnau, F., & Porras-Chavarino, A. (2003) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00038-1 · Cited by 14
Venlafaxine versus other anti-depressive agents for depression
Cipriani, A., Signoretti, A., Furukawa, T. A., Churchill, R. C., Tomelleri, S., Omori, I. M., McGuire, H., & Barbui, C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006530 · Cited by 13
Self-citationMoclobemide and sertraline in the treatment of depressive disorders: a comparative study.
Orsel Donbak, S., Mh, T., Ez, O. K., Demirergi, N., Akdemir, A., Şirin, A., & Ozbay, M. (1995) · PubMed · Cited by 12
Citalopram versus other anti-depressive agents for depression
Imperadore, G., Cipriani, A., Signoretti, A., Furukawa, T. A., Watanabe, N., Churchill, R. C., McGuire, H., Barbui, C., & Purgato, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534 · Cited by 12
Self-citationFluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., Furukawa, T. A., & Ant, M.-A. O. N. G. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114 · Cited by 7
Self-citationVenlafaxine vs imipramine, sertraline in treating depression
Chen, Z. (2001) · Chinese Journal of New Drugs and Clinical Remedies · Cited by 4
Research works printed but not linked: 23
- Khoury, 1998, Effect of sertraline and paroxetine treatment on depression scores and peripheral indices of serotonergic function in major depression, 11th European College of Neuropsychopharmacology Congress. Paris, France. 31st October 4th November 1998
- Behan, 1995, 5-HT reuptake inhibitors in CFS, EOS Rivista di Immunologia ed Immunofarmacologia, 15, 66
- Cohn, 1990, Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients, Journal of Clinical Psychiatry, 51, 28
- Fournier, 1997, A double-blind comparison of sertraline and imipramine in outpatients with major depression: Acute (8 weeks) and continuation (16 weeks) treatment, Human Psychopharmacology, 12, 203, 10.1002/(SICI)1099-1077(199705/06)12:3<203::AID-HUP849>3.0.CO;2-V · doi:10.1002/(sici)1099-1077(199705/06)12:3<203::aid-hup849>3.0.co;2-v
- Hegerl, 1997, Sertraline versus amitriptyline in hospitalized patients with major depression, Pharmacopsychiatry, 30, 175
- Kamijima, 1997, A double-blind, group comparison study of sertraline by hydrochloride vs amitriptyline hydrochloride, Japanese Journal of Neuropsychopharmacology, 19, 529
- Lee, 1994, Efficacy of sertraline in dysthymia, Neuropsychopharmacology, 10, 222S
- Li, 2001, A comparative study of sertraline and maprotiline in the treatment of depression, Shandong Journal of Psychological Medicine, 14, 173
- Murasaki, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor for depression and depressive state-A double-blind study compared with imipramine hydrochloride, Japanese Journal of Meuropsychopharmacology, 19, 505
- Tsutsui, 1997, Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor in the treatment of depression and depressive state: a double-blind, group comparison study of sertraline hydrochloride vs trazodone hydrochloride, Shinkeiseishinyakuri, 19, 549
- Gonul, 1999, Selective serotonin reuptake inhibitors: discontinuation rates due to side effects, European Neuropsychopharmacology, 9, 215, 10.1016/S0924-977X(99)80132-1 · doi:10.1016/s0924-977x(99)80132-1
- American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-III) 3rd Edition Washington, DC American Psychiatric Association
- 1987, Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R)
- 1994, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition
- Cipriani, 2007, Escitalopram versus other antidepressive agents for depression. (Protocol), Cochrane Database of Systematic Reviews
- Geddes, 2000, Selective serotonin reuptake inhibitors (SSRIs) for depression, Cochrane Database of Systematic Reviews
- Geddes, 2004, Depressive disorders, Clinical Evidence, 12, 1391
- Guy, 1970, Manual for the ECDEU Assessment Battery.2
- 2004, Depression: management of depression in primary and secondary care
- 1978, The Ninth Revision of the International Classification of Diseases and Related Health Problems (ICD-9)
- 1982, The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10)
- 2001, World Health Report 2001: Mental Health: New Understanding, New Hope
- Wing, 1994, Measuring mental health outcomes: a perspective from the Royal College of Psychiatrists. Outcomes into Clinical Practice. London:
Cited by
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Self-citationA comparative review of escitalopram, paroxetine, and sertraline: are they all alike?
Sanchez, C., Reines, E. H., & Montgomery, S. A. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000023 · Cited by 295
Lavretsky, H., Alstein, L. L., Olmstead, R. E., Ercoli, L. M., Riparetti-Brown, M., St. Cyr, N., & Irwin, M. R. (2011) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31820ee9ef · Cited by 268
Fluoxetine versus other types of pharmacotherapy for depression
Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 252
Self-citation
Metadata
- Authors
- Cipriani, A., La Ferla, T., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R., McGuire, H., & Barbui, C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2009-04-15
- Issue
- 2
- Pages
- CD006117-CD006117
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4243810801
- Cited by
- 305
- References
- 111
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.